The Department of Translational Hematology & Oncology Research conducts cancer research to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patient care.
More About UsThe Omar Mian lab studies the genetic and epigenetic mechanisms underlying lethal genitourinary cancers.
Learn MoreThe Yogen Saunthararajah lab studies how to selectively target and eliminate cancer cells without harming healthy cells.
Learn MoreThe Li Lilly Wang lab studies how immune checkpoint proteins regulate anti-tumor immune responses.
Learn MorePrecision cancer medicine is the goal of a new multidisciplinary study, led by Dr. Tim Chan, examining radiation therapy combined with targeted therapy
The program, which has funded 21 research teams since 2015, has a proven record of supporting projects that go on to attract large external grants.
Latest novel finding adds to list of cancers associated with the HSD3B1 gene; clinical and research teams investigating potential connections.
Exciting investigation and groundbreaking discovery happens every day at Cleveland Clinic. Join our team of expert researchers at the Department of Translational Hematology & Oncology Research.
View Careers